Chargement en cours...
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients
Pancreatic cancer remains a lethal disease that responds poorly to multiple types of treatment. Therefore, the identification of distinct subgroups that exhibit unique therapeutic responses is an urgent requirement. In the present multicenter study (1,912 cases), the differences between the therapeu...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351346/ https://ncbi.nlm.nih.gov/pubmed/28356973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5501 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|